Why the study?
Is the ACE-insertion/deletion polymorphism associated with diabetic nephropathy in patients with diabetes mellitus?
Is the ACE-insertion/deletion polymorphism associated with diabetic nephropathy in patients with diabetes mellitus?
The ACE-insertion/deletion polymorphism may be associated with diabetic nephropathy in Asian patients with NIDDM, but not in Caucasian patients.
Answers are grounded in this paper and cite their sources.
Ethnic differences in ACE I/D-nephropathy association warrant caution in generalization; leaves open ancestry-specific validation in NIDDM.
Recent studies have implicated a variant of the angiotensin-converting enzyme gene (ACE), associated with increased activity of this enzyme, in the development and progression of diabetic nephropathy. This study provides a systematic review of all cross-sectional, case-control, and cohort studies in patients with insulin-dependent (IDDM) or non-insulin-dependent (NIDDM) diabetes mellitus of any race, examining the relationship between the ACE-insertion/deletion polymorphism and nephropathy. Nineteen studies in 21 populations published between 1994 and 1997 presenting data on 5336 patients were reviewed. Two investigators independently assessed the studies on methodologic quality, performance of study, and association between the ACE-insertion/deletion polymorphism and nephropathy. Separate analyses of the relationship between genotype and allele frequencies were performed for patients with IDDM and NIDDM by race, using Peto's odds ratio. In Caucasians with IDDM, pooling was not performed due to heterogeneity of the studies, but among the homogeneous studies, no association was detected. Likewise, no association was observed in Caucasian patients with NIDDM (odds ratio [OR], 1.10; 95% confidence interval [95% CI], 0.83 to 1.45). In Asian patients with NIDDM, the risk of nephropathy was increased in the presence of the DD or ID genotype (OR, 1.88; 95% CI, 1.42 to 2.85). Although this analysis fails to confirm an association between the ACE-insertion/deletion genotype and nephropathy in Caucasians with NIDDM or IDDM, a role for this genetic marker in Asian patients cannot be ruled out. However, due to methodologic limitations of individual studies, no definite conclusions can be drawn from this analysis. Clearly, more rigorous methodology needs to be applied in future studies.
No takes yet. Share an insight, caveat, or question.
Kunz et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: